<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04518267</url>
  </required_header>
  <id_info>
    <org_study_id>2019PPRC16</org_study_id>
    <secondary_id>2020-A00507-32</secondary_id>
    <nct_id>NCT04518267</nct_id>
  </id_info>
  <brief_title>Anger and Psychotrauma: Data From Military and Civilians</brief_title>
  <acronym>COPMiCiv</acronym>
  <official_title>Anger and Psychotrauma: Data From Military and Civilians</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Direction Centrale du Service de Santé des Armées</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Direction Centrale du Service de Santé des Armées</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post-Traumatic Stress Disorder (PTSD) is mainly associated with several emotions such as&#xD;
      anger, guilt or shame. By interfering with psychotherapeutic work these emotions can be&#xD;
      problematic. When suffering from PTSD, pervasive anger can also have relational consequences.&#xD;
      Anger and PTSD are mutually reinforcing: anger can aggravate PTSD symptoms and aggressive&#xD;
      behaviours, and conversely, PTSD promotes high levels of anger and aggression. A few&#xD;
      explanatory hypotheses have been proposed. In terms of personality factors, anger-treatment&#xD;
      may promote the severity of PTSD symptoms and the development of aggressive behaviours. In&#xD;
      terms of stressors, exposure to combat and combat-related moral harms could play a role in&#xD;
      the relationship between PTSD, anger and traumatic experiences over the course of life.&#xD;
      Finally, in clinical terms, in the presence of PTSD, anger and aggressive behaviours may be&#xD;
      triggered by substance abuse and depression.&#xD;
&#xD;
      Within the Anglo-Saxon literature, it is recognized that both civilians and military&#xD;
      personnel with PTSD exhibit high levels of anger, with a possible predominance among military&#xD;
      personnel. While we know that anger management mechanisms can be strongly influenced by&#xD;
      cultural aspects and the type of event, there is no data in the French population.&#xD;
&#xD;
      This study proposes to fill in our knowledge of anger-PSTD relationships in the French&#xD;
      population and by comparing civilian and military population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 21, 2020</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Anxiety score</measure>
    <time_frame>At enrollment</time_frame>
    <description>Spielberger's State-Trait Anger Expression Inventory-II (STAXI-II) will be used to assess anxiety</description>
  </primary_outcome>
  <primary_outcome>
    <measure>PTSD severity score</measure>
    <time_frame>At enrollment</time_frame>
    <description>Clinician-Administered Posttraumatic Stress Disorder Scale (CAPS-5) will be used to assess PTSD severity score. CAPS-5 score may range from 0 to 120 with higher scores meaning greater PTSD severity.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of life traumatic events</measure>
    <time_frame>At enrollment</time_frame>
    <description>Life Event Checklist (LEC) will be used to assess the number of traumatic events experienced by participants throughout their lifetime</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aggressivity score</measure>
    <time_frame>At enrollment</time_frame>
    <description>Aggressivity Questionnaire (AQ12) will be used to assess aggressivity score. AQ12 score may range from 6 to 72 with higher scores meaning higher aggressivity levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anger Rumination score</measure>
    <time_frame>At enrollment</time_frame>
    <description>Anger Rumination Scale (ARS) will be used to assess anger rumination score. ARS score may range from 19 to 76 with higher scores corresponding to greater levels of anger rumination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Alcohol consumption score</measure>
    <time_frame>At enrollment</time_frame>
    <description>Alcohol Use Identification Test (A.U.D.I.T.) will be used to assess alcohol consumption score Score ≥ 5: at risk use; Score ≥ 8 (7 in women): harmful use; Score ≥ 12 (11 in women): likely alcohol dependence</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Post-traumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>Civilian group</arm_group_label>
    <description>Participants with civilian status</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Military group</arm_group_label>
    <description>Participants with military status</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Structured clinical interview</intervention_name>
    <description>A structured clinical interview will be performed at enrollment.</description>
    <arm_group_label>Civilian group</arm_group_label>
    <arm_group_label>Military group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychological questionnaires</intervention_name>
    <description>Several psychological questionnaires will be performed at enrollment.</description>
    <arm_group_label>Civilian group</arm_group_label>
    <arm_group_label>Military group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population will be composed of participants suffering from PTSD, half of which&#xD;
        will have civilian status and the other half a military status.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  To have a PTSD diagnosis&#xD;
&#xD;
          -  To be at least 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  To suffer from trauma-related physical condition (including Traumatic Brain Injury)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Anaïs MARMUSE</last_name>
    <phone>328382250</phone>
    <phone_ext>+33</phone_ext>
    <email>anais.marmuse@intradef.gouv.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>3ème Centre médical des Armées</name>
      <address>
        <city>Lille</city>
        <zip>59001</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anais MARMUSE</last_name>
      <phone>328382250</phone>
      <phone_ext>+33</phone_ext>
      <email>anais.marmuse@intradef.gouv.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Cadillac</name>
      <address>
        <city>Lormont</city>
        <zip>33310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Samantha AL JOBOORY, MD</last_name>
      <email>samantha.aljoboory@ch-cadillac.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Léon-Jean Grégory de Thuir</name>
      <address>
        <city>Thuir</city>
        <zip>66301</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Philippe RAYNAUD, MD</last_name>
      <phone>468846620</phone>
      <phone_ext>+33</phone_ext>
      <email>philippe.raynaud@ch-thuir.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Paul Guiraud</name>
      <address>
        <city>Villejuif</city>
        <zip>94806</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claire GRANIER, MD</last_name>
      <phone>142117230</phone>
      <phone_ext>+33</phone_ext>
      <email>granier.claire@hotmail.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>August 15, 2020</study_first_submitted>
  <study_first_submitted_qc>August 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2020</study_first_posted>
  <last_update_submitted>March 8, 2021</last_update_submitted>
  <last_update_submitted_qc>March 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Traumatic</mesh_term>
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

